Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.24% |
| 2 | Financials | 5.68% |
| 3 | Healthcare | 5.62% |
| 4 | Consumer Discretionary | 5.04% |
| 5 | Industrials | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5151
Minerva Neurosciences
NERV
$206M
| $146K | ﹤0.01% |
1,456
+1,167
| +404% | +$87.7K |
|
5152
NLI Holdings
NL
$313M
| $146K | ﹤0.01% |
24,246
+3,856
| +19% | +$30.7K |
|
5153
CALL
Direxion Daily 20+ Year Treasury Bear 3X ETF
TMV
$194M
| $146K | ﹤0.01% |
2,800
-13,760
| -83% | -$677K |
|
5154
CALL
Applied Optoelectronics
AAOI
$11.4B
| $145K | ﹤0.01% |
5,900
-3,300
| -36% | -$129K |
|
5155
CALL
Invesco CurrencyShares Canadian Dollar Trust
FXC
$73.7M
| $145K | ﹤0.01% |
1,900
-1,400
| -42% | -$106K |
|
5156
CALL
Gray Television
GTN
$490M
| $145K | ﹤0.01% |
8,300
| – | – |
|
5157
Ribbon Communications
RBBN
$356M
| $145K | ﹤0.01% |
21,149
+17,280
| +447% | +$123K |
|
|
POLY
5158
PUT
DELISTED
Plantronics, Inc.
POLY
| $145K | ﹤0.01% |
+2,400
| New | +$164K |
|
|
AXAS
5159
DELISTED
Abraxas Petroleum Corp
AXAS
| $145K | ﹤0.01% |
3,101
+1,532
| +98% | +$75.2K |
|
|
REV
5160
CALL
DELISTED
Revlon, Inc.
REV
| $145K | ﹤0.01% |
6,500
+6,200
| +2,067% | +$117K |
|
5161
eGain
EGAN
$203M
| $144K | ﹤0.01% |
17,706
+16,410
| +1,266% | +$207K |
|
5162
RB Global
RBA
$16.6B
| $144K | ﹤0.01% |
3,991
+2,491
| +166% | +$89.1K |
|
5163
Syndax Pharmaceuticals
SNDX
$1.81B
| $144K | ﹤0.01% |
17,933
+7,739
| +76% | +$55.2K |
|
|
APTX
5164
DELISTED
Aptinyx Inc. Common Stock
APTX
| $144K | ﹤0.01% |
+4,983
| New | +$121K |
|
5165
Clean Energy Fuels
CLNE
$377M
| $143K | ﹤0.01% |
54,841
-2,518
| -4% | -$7.01K |
|
5166
CALL
iShares MSCI Germany ETF
EWG
$1.68B
| $143K | ﹤0.01% |
4,800
-9,600
| -67% | -$291K |
|
5167
Goosehead Insurance
GSHD
$2.32B
| $143K | ﹤0.01% |
4,239
+3,522
| +491% | +$102K |
|
5168
iShares Select U.S. REIT ETF
ICF
$2.07B
| $143K | ﹤0.01% |
2,862
| – | – |
|
5169
CALL
Jack in the Box
JACK
$341M
| $143K | ﹤0.01% |
1,700
-1,500
| -47% | -$130K |
|
5170
SIGA Technologies
SIGA
$207M
| $143K | ﹤0.01% |
20,729
+16,920
| +444% | +$124K |
|
|
ELOX
5171
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
| $143K | ﹤0.01% |
210
+171
| +438% | +$109K |
|
|
DERM
5172
DELISTED
Dermira, Inc.
DERM
| $143K | ﹤0.01% |
13,100
+9,595
| +274% | +$96.8K |
|
|
DX
5173
Dynex Capital
DX
$3.21B
| $142K | ﹤0.01% |
7,428
+6,104
| +461% | +$117K |
|
5174
Entravision Communication
EVC
$852M
| $142K | ﹤0.01% |
29,163
+22,064
| +311% | +$110K |
|
5175
CALL
Prospect Capital
PSEC
$1.14B
| $142K | ﹤0.01% |
19,400
+3,300
| +20% | +$23.3K |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.